Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm...
Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the...
News Release Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s...
Ad hoc announcement pursuant to Art. 53 LR Vanrafia can be seamlessly added to supportive care in IgAN and used...
To be presented at 11th Annual Immunotherapy of Cancer (ITOC) Conference in Munich, Germany Marlborough, Massachusetts--(Newsfile Corp. - April 3,...
Completed enrollment in the chronic cohort and commenced enrollment in the subacute cohort of its Phase 1b/2a clinical trial for...
Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the...
KANAZAWA, Japan, April 3, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University and colleagues have developed a...
SCOTTSDALE, Ariz., April 2, 2025 /PRNewswire/ -- The Pause Technologies, a real-time AI platform dedicated to menopause support, announces the...
SEOUL, South Korea, April 3, 2025 /PRNewswire/ -- As the social atmosphere emphasizes the importance of mental health care and depression...